![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Switzerland
Find below all kinds of persons from Switzerland (Schweiz / Suisse).Total search results: 1254 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Nuechterlein, Carole (Roche 201604 Head of Roche Venture Fund) | Investment Manager | Roche (Group) | Northwestern Switzerland (region) |
| Nuernberger, Falk (Rentschler 202207– Corporate General Counsel before Viatris + MediGene + Sandoz + Actavis) | General Counsel / Chief Legal Officer (CLO) | Rentschler (Group) | Baden-Württemberg (federal state) |
| Núnez-Garcia, Sara (Forty51 Advisors 202204– Partner + Co-Founder formerly Sofinnova Partners 201410 Associate) | Partner (venture partner) | Forty51 Ventures (Group) | Northwestern Switzerland (region) |
| O'Day, Daniel (Gilead 201903 CEO before Roche Pharma CEO + COO + Roche Diagnostics COO joined Roche 1987) | Chief Executive Officer (CEO) | Gilead Sciences (Group) | California (federal state) |
| Oberhänsli, Walter (Zur Rose Group 202007 CEO) | Chief Executive Officer (CEO) | Zur Rose Group (Group) | Eastern Switzerland (region) |
| Obrecht, Daniel (Polyphor 201107 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Spexis (Group) | Northwestern Switzerland (region) |
| Obrecht, Jean-Pierre (Polyphor 201504 Non-executive Board Director before CEO + Co-Founder) | Chief Executive Officer (CEO) | Spexis (Group) | Northwestern Switzerland (region) |
| Oehlers, Dirk (Lonza 201610 Head Investor Relations) | Public Relations Manager / Investor Relations Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Oesch, Bruno (Neurotune 200903– CEO before co-founder + Board Chairman) | Chief Executive Officer (CEO) | Neurotune AG | Zürich (region) |
| Ofner, Alessandro (Microcaps 202101 Co-CEO + Co-Founder) | Chief Executive Officer (CEO) | Microcaps AG | Zürich (region) |
| Ogunshola, Lara (Lipidon 201808 Chief Marketing Officer) | Sales Manager / Marketing Manager | Lipidon AG (Lipidon Analytics) | Zürich (region) |
| Ollier, Michèle (Medixci Ventures 201602– General Partner before Index Ventures + Funxional Therapeutics) | General Partner (venture partner) | Medicxi Ventures (formerly Index Ventures Life Sciences) | Greater London (region) |
| Olvany, Sophie (Nemis Technologies 202202 Business Development Executive) | Business Development Manager / Strategy Manager | Nemis Technologies AG | Zürich (region) |
| Onakunle, Yemi (JSR Corp 202001– promoted to CBO of Selexis joined 2012 before Diosynth RTP Inc + Lonza) | Chief Business Officer (CBO) | JSR Corporation (Group) | Région Lémanique (region) |
| Ondish, Mary Ann (ADC Therapeutics 202206 Media Relations) | Public Relations Manager / Investor Relations Manager | ADC Therapeutics (Group) | Région Lémanique (region) |
| Onuscheck, Michael (Novartis 201810 President Global Business + Innovation at Alcon) | Business Development Manager / Strategy Manager | Novartis (Group) | Central Switzerland (region) |
| Oroszlan, Peter (Zeptosens 200404 Director Business Development) | Business Development Manager / Strategy Manager | Bayer (Group) | Espace Mittelland (region) |
| Osswald, Ulrich (Lonza 202306 VP Licensing) | IP Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Osterwalder, Bruno (Roche + Merck Serono) | n. a. | Roche (Group) | Northwestern Switzerland (region) |
| Ostrout, Nicholas (Lonza 202112 Senior Director Business Strategy + Implementation Personal Medicine) | Business Development Manager / Strategy Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Ounzain, Samir (Haya Therapeutics 202105 CEO + Co-Founder) | Chief Executive Officer (CEO) | Haya Therapeutics S.A. | Région Lémanique (region) |
| Ovaskainen, Jari | n. a. | Preon Capital (family office of Jari Ovaskainen) | Région Lémanique (region) |
| O’Connell, Alan (Seroba Life Sciences 201702 Partner joined 2003 before Elan Corp + American Biogenetic Sciences) | Partner (venture partner) | Seroba (Group) | Ireland (cl4) |
| O’Day, Daniel (Gilead 201903– CEO before Roche Pharma CEO + COO + Roche Diagnostics COO joined Roche 1987) | Chief Executive Officer (CEO) | Gilead Sciences (Group) | California (federal state) |
| Palazzo, Guido (Univ Lausanne 202309 Prof of Business Ethics) | Professor | University of Lausanne (UNIL) | Région Lémanique (region) |
| Pao, William (Roche 201804– Head of Pharma Research and Early Development pRED joined 2014 before Vanderbilt Univ) | President/Director/Head Business Group/Unit/Division | Roche (Group) | Northwestern Switzerland (region) |
| Papadimitriou, Apollon (iOmx Therapeutics 201910– CEO joined 2017 as CDO before Roche) | Chief Executive Officer (CEO) | iOmx Therapeutics AG | Bayern (federal state) |
| Papatheodorou, Elias (Genkyotex 201707 before Covagen + Medigene + Novosom + A.T.I. + Coca-Cola + Philip Morris) | Chief Executive Officer (CEO) | Calliditas Therapeutics (Group) | Occitanie (Occitania) (region) |
| Parekh, Nayan Gregory (Biocartis 201111– CEO before Executive Director before New Rhein Healtchare + Novartis) | Chief Executive Officer (CEO) | Biocartis (Group) | Région Lémanique (region) |
| Parel, Serge (Exquiron Biotech AG 201306 VP Chemistry + Research Informatics) | Research & Development Manager | Evotec (Group) | Northwestern Switzerland (region) |
| Pasini, Alexandre (Celonic 202110– COO before SaniSure Group + Lonza Group) | Chief Operating Officer (COO) | Celonic (Group) | Northwestern Switzerland (region) |
| Pauer, Michael (Occident Group 201604 Investment Director) | Investment Manager | Occident (Group) | Central Switzerland (region) |
| Paulsen, Frederik (Ferring 201911 Chairman) | Board member | Ferring (Paulsen Foundation) (Group) | Switzerland_other |
| Pauwels, Rudi (Biocartis 201111 Executive Chairman before 201002–201111 CEO) | Chief Executive Officer (CEO) | Biocartis (Group) | Région Lémanique (region) |
| Pawlak, Michael (Zeptosens Co-Founder) | Company Founder | Bayer (Group) | Espace Mittelland (region) |
| Pè, Giulio (Mettler-Toledo 200704 General Manager) | General Manager (management) | Mettler-Toledo (Mettler Toledo) (Group) | Zürich (region) |
| Pein, Claus-Dietmar (Lonza 201211 Global Head of Marketing Lonza Bioscience Research and Testing Products) | Sales Manager / Marketing Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Pejowski, David (Adoram Therapeutics 202210 CEO + Co-Founder) | Chief Executive Officer (CEO) | Switzerland_other | |
| Pelkmans, Lucas (ETH Zurich 200603) | n. a. | ETH Zürich (ETHZ) | Zürich (region) |
| Perron, Hervé (GeNeuro 201702 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | GeNeuro S.A. (Euronext Paris: GNRO) | Région Lémanique (region) |
| Perry, Benjamin (DNDi 201909 Senior Discovery Manager + Research Scientist) | n. a. | DNDi (Drugs for Neglected Diseases initiative) | Région Lémanique (region) |
| Peters, Björn (CDR-Life 202204 CBO) | Chief Business Officer (CBO) | CDR-Life AG | Zürich (region) |
| Petkov, Jordan (Lonza 201703– Global Head of Research + Technology at Lonza Consumer Care before KLK POleo + Unilever) | Research & Development Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Petrone, Raffaele (Therametrics 201310– CEO) | Chief Executive Officer (CEO) | Relief Therapeutics (Group) | Central Switzerland (region) |
| Pfannes, Othmar (Genedata 200406 CEO) | Chief Executive Officer (CEO) | Genedata (Group) | Northwestern Switzerland (region) |
| Pfister, Bernd (Invision 200610 CEO) | Chief Executive Officer (CEO) | Invision (Group) | Central Switzerland (region) |
| Philippe, Olivier (GeneBio 201005 Sales + Marketing Director) | Sales Manager / Marketing Manager | GeneBio (Group) | Région Lémanique (region) |
| Philippsen, Peter | n. a. | University of Basel | Northwestern Switzerland (region) |
| Philips, Julien (Genedata 201006 Product Manager) | Product Manager (personnel) | Genedata (Group) | Northwestern Switzerland (region) |
| Picard, Emmanuel (Chemie Brunschwig 201509 Marketing + Sales Manager) | Sales Manager / Marketing Manager | Chemie Brunschwig AG | Northwestern Switzerland (region) |
| Picaud, Géraldine (SGS 202403– CEO joined 202312 as CFO before Holcim + Essilor + Safic Alcan + ED&F Man Group) | Chief Executive Officer (CEO) | SGS (Group) | Région Lémanique (region) |
| Pichler, Peter (Brechbühler 201709 General Manager) | General Manager (management) | Brechbühler AG | Zürich (region) |
| Pickering, Catherine (iOnctura 201706– CEO + Co-Founder before Merck Head Global Oncology Licensing + BusDev) | Chief Executive Officer (CEO) | iOnctura (Group) | Région Lémanique (region) |
| Picotti, Paola (ETH Zürich 202008 Assoc Professor in Molecular Systems Biology + Group Leader) | Assistant Professor / Associate Professor | ETH Zürich (ETHZ) | Zürich (region) |
| Piëch, Valentin (BioMedPartners 202205 Partner) | Partner (venture partner) | BioMedPartners (Group) | Northwestern Switzerland (region) |
| Planje, Paul (Vialis 201103 Director of Sales) | Sales Manager / Marketing Manager | Vialis (Group) | Northwestern Switzerland (region) |
| Platzer, Erich (HBM Bioventures 200604) | Investment Manager | HBM (Group) | Central Switzerland (region) |
| Plewman, Patrick (Biognosys 201212– CEO before diaDexus CEO before SKB) | Chief Executive Officer (CEO) | Bruker (Group) | Zürich (region) |
| Plitz, Thomas (Tom) (Chord Therapeutics 202010 CEO before CSO at Wilson Therapeutics) | Chief Executive Officer (CEO) | Merck (DE) (Group) | Région Lémanique (region) |
| Plodinec, Marija (Artidis 202011 CEO + Co-Founder) | Chief Executive Officer (CEO) | Artidis AG | Northwestern Switzerland (region) |
| Ploos van Amstel, Arnout (MoonLake 202105– COO + Co-Founder) | Chief Operating Officer (COO) | MoonLake Immunotherapeutics AG | Central Switzerland (region) |
| Plückthun, Andreas (Univ Zurich 200605) | Board member, non-executive | University of Zurich (UZH) | Zürich (region) |
| Pochert, Jörg (Hamilton 201608 VP Life Science Robotics at Hamilton Bonadzu) | President/Director/Head Business Group/Unit/Division | Hamilton (Group) | Eastern Switzerland (region) |
| Poehling, Sylke (Roche 201312 Head of Large Molecule Research) | President/Director/Head Business Group/Unit/Division | Roche (Group) | Northwestern Switzerland (region) |
| Poli, Sonia (Addex 201501 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Addex (Group) | Région Lémanique (region) |
| Polymeropoulos, Mihal H. (Vanda Pharmaceuticals 200211– founder + CEO before Novartis AG) | Chief Executive Officer (CEO) | Vanda Pharmaceuticals (Group) | Maryland (federal state) |
| Ponnier, Nathalie (Vifor Pharma 202111 Global Head Corporate Communications) | Public Relations Manager / Investor Relations Manager | Vifor Pharma (Group) | Zürich (region) |
| Porter, Mark (Qiagen Instruments 200705) | n. a. | Qiagen (Group) | Zürich (region) |
| Porter, Richard (Corlieve 201911– CEO + Co-Founder before Therachon + Roche + Shire + Vernalis + Astra) | Chief Executive Officer (CEO) | Corlieve Therapeutics SAS | Île-de-France (region) |
| Posch, Johannes (Tecan 200506) | n. a. | Tecan (Group) | Zürich (region) |
| Post, James (PHC 202002 President of Epredia) | President/Director/Head Business Group/Unit/Division | PHC (Group) | New Hampshire (federal state) |
| Pothula, Kanishka (Nextech Invest 202403 Managing Partner before BVF Partners) | Managing Partner (investment firm) | Nextech (Group) | Zürich (region) |
| Potter, Myrtle (Roivant 201910 Vant Operating Chair at Roivant Pharma before Genentech + BMS) | n. a. | Roivant (Group) | Northwestern Switzerland (region) |
| Pragnell, Michael (Syngenta –200707– CEO) | Chief Executive Officer (CEO) | Syngenta (Group) | Northwestern Switzerland (region) |
| Prasad, Raju (CRISPR Therapeutics 202303– CFO before William Blair) | Chief Financial Officer (CFO) | CRISPR Therapeutics (Group) | Northwestern Switzerland (region) |
| Princen, Marc (Takeda 201411– President Europe + Canada business unit before Merck + Schering-Plough) | President/Director/Head Business Group/Unit/Division | Takeda (Group) | Zürich (region) |
| Puylaert, Kevin (Sophia Genetics 202002 VP Business Development) | Business Development Manager / Strategy Manager | Sophia Genetics (Group) | Région Lémanique (region) |
| Raab, Martin (Endress+Hauser 201604 Head Public + Internal Communication) | Public Relations Manager / Investor Relations Manager | Endress+Hauser (Group) | Northwestern Switzerland (region) |
| Raetzman, Stuart (Alcon 201101 VP Global Marketing + General Manager US Business) | Sales Manager / Marketing Manager | Novartis (Group) | Central Switzerland (region) |
| Raman, Prakash (Flagship Pioneering 201911– Senior Partner + Chief BusDev Officer before Novartis NIBR + AstraZeneca) | Partner (venture partner) | Flagship Pioneering | Massachusetts (federal state) |
| Ramaswamy, Vivek (Roivant Sciences 201708 CEO + Founder) | Chief Executive Officer (CEO) | Roivant (Group) | Northwestern Switzerland (region) |
| Ramsay, John (Syngenta 200707– CFO) | Chief Financial Officer (CFO) | Syngenta (Group) | Northwestern Switzerland (region) |
| Raquet, Line Stigen (Creoptix 202001– CEO before Mettler-Toledo + Qiagen) | Chief Executive Officer (CEO) | Spectris (Group) | Zürich (region) |
| Raths, Jürgen (Paion 201509–201703 COO before Executive Insight + Correvio Intl + Arpida + Lilly LEFT 3/17) | Chief Operating Officer (COO) | Humanwell Healthcare (Group) | Nordrhein-Westfalen (federal state) |
| Rayment, Cary (Alcon –200709– President, Chairman + CEO) | Chief Executive Officer (CEO) | Novartis (Group) | Central Switzerland (region) |
| Rebeaud, Fabien (Abionic 201909 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Abionic S.A. | Région Lémanique (region) |
| Reddy, David (Roche 200611 Influenza Pandemic Taksforce Leader) | n. a. | Roche (Group) | Northwestern Switzerland (region) |
| Reddy, Sai (deepCDR Biologics 202112 Founder + Associate Prof at ETH Zurich Dept of Biosystems Science + Engineering) | Company Founder | Alloy Therapeutics (Group) | Northwestern Switzerland (region) |
| Reed, John C. (Sanofi 201807– Global Head RnD before Roche 2013–201804 Head of pRED LEFT) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Reeks, Toby (SGS 202012 SVP Investor Relations + Corporate Communciations + Sustainability) | Public Relations Manager / Investor Relations Manager | SGS (Group) | Région Lémanique (region) |
| Reich, Kristian (MoonLake 202105– CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | MoonLake Immunotherapeutics AG | Central Switzerland (region) |
| Reim, Wolfgang (BB Medtech 200705– Verwaltungsrat) | n. a. | Bellevue (Group) | Zürich (region) |
| Reinhardt, Jörg (Novartis 201308– Board Chairman before Bayer 201008– CEO Bayer HealthCare AG before Novartis COO) | Board member, non-executive | Novartis (Group) | Northwestern Switzerland (region) |
| Reinisch, Peter H. (Global Life Science Ventures 201105 Managing Director GLSV CH) | Managing Director | Global Life Science Ventures (Group) | Central Switzerland (region) |
| Reiter, Lukas (Biognosys 201401– Head RnD before Head of Bioinformatics before ETHZ) | Research & Development Manager | Bruker (Group) | Zürich (region) |
| Renggli, Jost (Venture Valuation 201602 COO) | Chief Operating Officer (COO) | Venture Valuation (Group) | Zürich (region) |
| Rentsch, Christoph (Santhera 201507– CFO before Polyphor + Caperis Ltd + Roche + Lonza) | Chief Financial Officer (CFO) | Santhera (Group) | Northwestern Switzerland (region) |
| Rentsch, Ian (Clinerion 201804– CEO before Iqvia/Quintiles since 2012) | Chief Executive Officer (CEO) | Clinerion (Group) | Northwestern Switzerland (region) |
| Reymond, Christophe (Anergis 201103 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Anergis S.A. | Région Lémanique (region) |
| Reymond, Frédéric (DiagnoSwiss 200507 Managing Director + co-founder) | Managing Director | Diagnoswiss S.A. | Région Lémanique (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
